Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Clin+Liver+Dis 2016 ; 20 (4): 737-49 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Towards Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities #MMPMID27742011
Sebastien B; Leda B; Maryam E; Schinazi RF
Clin Liver Dis 2016[Nov]; 20 (4): 737-49 PMID27742011show ga
With nearly 30% of the world population infected, hepatitis B virus (HBV) causes significant morbidity and mortality worldwide. Although several potent antiviral agents are currently in use against HBV infection, the majority of chronically infected individuals do not achieve a functional and complete cure, as measured by the clearance of HB surface antigen (HBsAg) from blood and eradication of the covalently closed-circular DNA (cccDNA) from the nuclei of hepatocytes. In addition, even treated persons who achieve a long-term (> 10-15 years) sustained virological response (undetectable HBV DNA), are still at high risk of developing morbidity and mortality from liver complications. This review focuses upon novel, mechanistically diverse anti-HBV therapeutic strategies that are currently in development or in clinical evaluation, and highlights new combination strategies which may contribute to full elimination of HBV DNA and cccDNA from the infected liver, leading to a complete cure of chronic hepatitis B.